首页>
美国卫生研究院文献>BMC Rheumatology
>Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE a phase 3B multicenter randomized double-blind placebo-controlled study
【2h】
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE a phase 3B multicenter randomized double-blind placebo-controlled study